Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-ranging study of RO4389620 plus metformin in type 2 diabetes mellitus
2005-002908-42Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing RO4389620 + metformin with Placebo + metformin (2 arms). Primary endpoint: Change in HbA1c from baseline. Started Aug 2005; status: completed.
02
Drugs
piragliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-002908-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002908-42.